Ampullary cancer ESPAC-3 (v2) trial: A multicenter, international, open-label, randomized controlled phase III trial of adjuvant chemotherapy versus observation in patients with adenocarcinoma of the ampulla of vater

被引：0
|
作者：
Neoptolemos, J. P.
Moore, M. J.
Cox, T. F.
Valle, J. W.
Palmer, D. H.
Mcdonald, A.
Carter, R.
Tebbutt, N. C.
Dervenis, C.
Smith, D.
Glimelius, B.
Coxon, F. Y.
Lacaine, F.
Middleton, M. R.
Ghaneh, P.
Bassi, C.
Halloran, C.
Olah, A.
Rawcliffe, C. L.
Buechler, M. W.
机构：
[1] Univ Liverpool, Liverpool L69 3BX, Merseyside, England
[2] Princess Margaret Hosp, Dept Med Oncol, Toronto, ON M4X 1K9, Canada
[3] Univ Toronto, Toronto, ON, Canada
[4] Christie NHS Fdn Trust, Dept Med Oncol, Manchester, Lancs, England
[5] CRUK Inst Canc Studies, Birmingham, W Midlands, England
[6] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland
[7] Glasgow Royal Infirm, Glasgow G4 0SF, Lanark, Scotland
[8] Austin Hosp, Ludwig Oncol Unit, Heidelberg, Vic 3084, Australia
[9] Aiga Olga Hosp, Athens, Greece
[10] Clatterbridge Ctr Oncol NHS Fdn Trust, Wirral, Merseyside, England
[11] Akad Univ Hosp, Uppsala, Sweden
[12] Northern Ctr Canc Care, Newcastle Upon Tyne, Tyne & Wear, England
[13] Hosp Tenon, Paris, France
[14] Oxford Radcliffe Hosp, Oxford, England
[15] Univ Verona, Dept Surg, I-37100 Verona, Italy
[16] Petz Aladar Cty Hosp, Gyor, Hungary
[17] Heidelberg Univ, Heidelberg, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LBA4006
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Re: Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma (the POUT Trial): A Phase 3, Open-label, Randomised Controlled Trial
    D'Andrea, David
    Pradere, Benjamin
    Shariat, Shahrokh F.
    EUROPEAN UROLOGY, 2021, 79 (01) : 163 - 164
  • [22] Health-related Quality of Life Following Hybrid Minimally Invasive Versus Open Esophagectomy for Patients With Esophageal Cancer, Analysis of a Multicenter, Open-label, Randomized Phase III Controlled Trial The MIRO Trial
    Mariette, Christophe
    Markar, Sheraz
    Dabakuyo-Yonli, Tienhan Sandrine
    Meunier, Bernard
    Pezet, Denis
    Collet, Denis
    D'Journo, Xavier Benoit
    Brigand, Cecile
    Perniceni, Thierry
    Carrere, Nicolas
    Mabrut, Jean Yves
    Msika, Simon
    Peschaud, Frederique
    Prudhomme, Michel
    Bonnetain, Franck
    Piessen, Guillaume
    ANNALS OF SURGERY, 2020, 271 (06) : 1023 - 1029
  • [23] Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary Adenocarcinoma: The ESPAC-3 Periampullary Cancer Randomized Trial (vol 308, pg 147, 2012)
    Neoptolemos, John P.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (18): : 1861 - 1861
  • [24] Perioperative versus adjuvant S-1 plus oxaliplatin chemotherapy for stage II/III resectable gastric cancer (RESONANCE): a randomized, open-label, phase 3 trial
    Wang, Xinxin
    Lu, Canrong
    Wei, Bo
    Li, Shuo
    Li, Ziyu
    Xue, Yingwei
    Ye, Yingjiang
    Zhang, Zhongtao
    Sun, Yihong
    Liang, Han
    Li, Kai
    Zhu, Linghua
    Zheng, Zhichao
    Zhou, Yanbing
    He, Yulong
    Li, Fei
    Wang, Xin
    Liang, Pin
    Huang, Hua
    Li, Guoli
    Shen, Xian
    Ji, Jiafu
    Tang, Yun
    Xu, Zekuan
    Chen, Lin
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2024, 17 (01) : 17
  • [25] Perioperative versus adjuvant S-1 plus oxaliplatin chemotherapy for stage II/III resectable gastric cancer (RESONANCE): a randomized, open-label, phase 3 trial
    Xinxin Wang
    Canrong Lu
    Bo Wei
    Shuo Li
    Ziyu Li
    Yingwei Xue
    Yingjiang Ye
    Zhongtao Zhang
    Yihong Sun
    Han Liang
    Kai Li
    Linghua Zhu
    Zhichao Zheng
    Yanbing Zhou
    Yulong He
    Fei Li
    Xin Wang
    Pin Liang
    Hua Huang
    Guoli Li
    Xian Shen
    Jiafu Ji
    Yun Tang
    Zekuan Xu
    Lin Chen
    Journal of Hematology & Oncology, 17
  • [26] Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma: An Open-Label, Multicenter, Phase III Randomized Trial
    Bayman, Neil
    Appel, Wiebke
    Ashcroft, Linda
    Baldwin, David R.
    Bates, Andrew
    Darlison, Liz
    Edwards, John G.
    Ezhil, Veni
    Gilligan, David
    Hatton, Matthew
    Jegannathen, Apurna
    Mansy, Talal
    Peake, Michael D.
    Pemberton, Laura
    Rintoul, Robert C.
    Snee, Michael
    Ryder, W. David
    Taylor, Paul
    Faivre-Finn, Corinne
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (14) : 1200 - +
  • [27] First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial
    Marth, Christian
    Moore, Richard G.
    Bidzinski, Mariusz
    Pignata, Sandro
    Ayhan, Ali
    Rubio, M. Jesus
    Beiner, Mario
    Hall, Marcia
    Vulsteke, Christof
    Braicu, Elena Ioana
    Sonoda, Kenzo
    Wu, Xiaohua
    Frentzas, Sophia
    Mattar, Andre
    Lheureux, Stephanie
    Chen, Xiaojun
    Hasegawa, Kosei
    Magallanes-Maciel, Manuel
    Choi, Chel Hun
    Shalkova, Mariia
    Kaen, Diego
    Wang, Peng-Hui
    Berger, Regina
    Okpara, Chinyere E.
    Mckenzie, Jodi
    Yao, Lili
    Orlowski, Robert
    Khemka, Vivek
    Gilbert, Lucy
    Makker, Vicky
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (09)
  • [28] Hybrid minimally invasive vs. open esophagectomy for patients with esophageal cancer: Long-term outcomes of a multicenter, open-label, randomized phase III controlled trial, the MIRO trial
    Mariette, C.
    Markar, S.
    Dabakuyo-Yonli, T. S.
    Meunier, B.
    Pezet, D.
    Collet, D.
    D'Journo, X. B.
    Brigand, C.
    Perniceni, T.
    Carrere, N.
    Bonnetain, F.
    Piessen, G.
    ANNALS OF ONCOLOGY, 2017, 28
  • [29] Adjuvant immunotherapy for resected esophageal squamous cell carcinoma with high risk of recurrence (AIRES): A multicenter, open-label, randomized, controlled phase III trial
    Kang, X.
    Xu, J.
    Zhang, R.
    Song, Y.
    Wang, Z.
    Zhang, B.
    Chen, X.
    Zheng, Q.
    Li, Y.
    Qin, J.
    Huang, J.
    Li, Y.
    He, J.
    ANNALS OF ONCOLOGY, 2021, 32 : S1072 - S1073
  • [30] A phase III randomized, open-label, controlled trial of chemotherapy and bevacizumab with or without panitumumab in the first-line treatment of patients with metastatic colorectal cancer
    Wainberg, Zev
    Hecht, J. Randolph
    CLINICAL COLORECTAL CANCER, 2006, 5 (05) : 363 - 367
12345